About LRRI

 

 

Lovelace Respiratory Research Institute is a private, biomedical research organization dedicated to improving public health through research on respiratory disease; biodefense countermeasures to other diseases; investigating environmental toxicology and human health; drug development; and studying mental illness and brain disorders.

 

 


 

Equipped with a broad range of technical expertise and a wealth of research capabilities, LRRI seeks to improve the public health through a variety of basic, applied and clinical biomedical research, and to find new treatments and cures for human disease.

In addition to LRRI's experience and expertise in respiratory research, LRRI  conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of  mental illness and other brain disorders.  

LRRI has formed a strategic partnership with Brigham and Women's Hospital of Harvard University.  The partnership leverages the clinical research excellence of BWH and the basic science and animal model expertise of LRRI. The goal is to foster cures for respiratory disease and drug development. 

The Institute readily opens its unique research facilities to university, government and private collaborators who are in pursuit of discovering new therapies and preventive treatments to disease. 

                                                                                                                                                                                                                                                                                                                                                                                                                    

Fast Facts
 

Founded: 1947, State of New Mexico, not-for-profit corporation
Employees: 120 PhD-level scientists, 691 technicians and support staff
Annual Budget: $92 million
Endowment: $45.5 million
Size of Facilities: 500,000 square feet
Funding Sources: Grants, contracts, philanthropy
Research Areas: Asthma, emphysema, lung cancer, inhalation toxicology, aerosol science, inhalation drug delivery, bronchitis, allergies, science service contracting, pulmonary fibrosis, pulmonary hypertension, infectious disease, radiation studies, chemical exposure research, clinical trials, specialized software for laboratory research, and neurobiological research.